{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:20:46Z","timestamp":1788808846561,"version":"build-2803163510"},"reference-count":60,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Appropriate antimicrobial dosing according to kidney function is essential to ensure therapeutic efficacy while minimizing toxicity and antimicrobial resistance. Despite established dosing guidelines and electronic prescribing systems, errors in renal dose adjustment of antimicrobials, particularly in the setting of acute kidney injury, remain common among hospitalized patients. Materials and Methods: A point-prevalence study was conducted on 31 October 2024 at a tertiary-care hospital in Greece to evaluate the appropriateness of antimicrobial dosing in relation to renal function. Patient characteristics, renal parameters, and antimicrobial prescriptions were extracted from electronic medical records. Glomerular filtration rate (GFR) was estimated using the MDRD formula. Comparative analyses were performed between correctly and incorrectly dosed cases, and between overdosing and underdosing episodes. Results: A total of 235 hospitalized patients were evaluated (mean age 64.8 \u00b1 18.6 years; 43.4% female). Overall, 15.7% (37\/235) received at least one antimicrobial dose inappropriate for their renal function. Among 37 patients where dosing errors were identified, overdosing was noted in 23 (62.2%), underdosing in 16 (43.2%), adding up to 39 prescriptions, while in 2 patients (5.4%), both mistakes were noted in different prescribed antimicrobials. Drug-specific error rates varied considerably: ceftazidime and cefuroxime showed the highest rates of inappropriate dosing (40% each), followed by colistin (33.3%) and acyclovir (33.3%). Piperacillin\/tazobactam, the most frequently prescribed agent (n = 50), had a 14% error rate, mainly due to underdosing (10%). Patients with dosing errors were significantly older (71.5 vs. 64.1 years, p = 0.0220) and had worse renal function, including higher serum creatinine (1.68 vs. 1.19 mg\/dL, p = 0.0174), lower GFR (58.5 vs. 75.9 mL\/min\/1.73 m2, p = 0.0009), and more frequent dialysis (13.5% vs. 4.3%, p = 0.0422). They also received a higher median number of antimicrobials (2 vs. 1, p = 0.0185). Conclusions: Inappropriate antimicrobial dosing based on kidney function remains common in hospitalized patients, particularly among older individuals and those with impaired renal function or polypharmacy. Targeted antimicrobial stewardship strategies focusing on renal dose adjustment and agents that are more frequently dosed inappropriately, such as colistin, acyclovir, cefuroxime, and ceftazidime, as well as agents that are frequently prescribed despite a relatively lower rate of inappropriate dose, such as piperacillin\/tazobactam, are needed to enhance prescribing safety and optimize therapeutic outcomes.<\/jats:p>","DOI":"10.3390\/medicina62040743","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:38:26Z","timestamp":1776080306000},"page":"743","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inappropriate Antimicrobial Dosing in Regard to Renal Function in a Tertiary Hospital in Greece\u2014A Single-Center Point Prevalence Study"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1082-5674","authenticated-orcid":false,"given":"Petros","family":"Ioannou","sequence":"first","affiliation":[{"name":"School of Medicine, University of Crete, 71003 Heraklion, Greece"},{"name":"Internal Medicine Department, University Hospital of Heraklion, 71110 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4320-0010","authenticated-orcid":false,"given":"Andria","family":"Papazachariou","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, University Hospital of Heraklion, 71110 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatis","family":"Karakonstantis","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Crete, 71003 Heraklion, Greece"},{"name":"Internal Medicine Department, University Hospital of Heraklion, 71110 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0255-5926","authenticated-orcid":false,"given":"Diamantis","family":"Kofteridis","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Crete, 71003 Heraklion, Greece"},{"name":"Internal Medicine Department, University Hospital of Heraklion, 71110 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ioannou, P., Astrinaki, E., Vitsaxaki, E., Bolikas, E., Christofaki, D., Salvaraki, A., Lagoudaki, E., Ioannidou, E., Karakonstantis, S., and Saplamidou, S. (2022). A Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in Public Acute Care Hospitals in Crete, Greece. Antibiotics, 11.","DOI":"10.3390\/antibiotics11091258"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jgar.2025.09.009","article-title":"Antimicrobial Utilization among Hospitalized Patients According to WHO AWaRe Classification: Results from a Multicentre Point Prevalence Survey in Saudi Arabia","volume":"45","author":"Alsaleh","year":"2025","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13756-020-00758-x","article-title":"The 2017 Global Point Prevalence Survey of Antimicrobial Consumption and Resistance in Canadian Hospitals","volume":"9","author":"Frenette","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1800393","DOI":"10.2807\/1560-7917.ES.23.46.1800393","article-title":"Antimicrobial Use in European Acute Care Hospitals: Results from the Second Point Prevalence Survey (PPS) of Healthcare-Associated Infections and Antimicrobial Use, 2016 to 2017","volume":"23","author":"Plachouras","year":"2018","journal-title":"Euro Surveill."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e002411","DOI":"10.1136\/bmjph-2024-002411","article-title":"Global Trends in Inappropriate Use of Antibiotics, 2000-2021: Scoping Review and Prevalence Estimates","volume":"3","author":"Mulchandani","year":"2025","journal-title":"BMJ Public Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bcpt.13986","article-title":"Inappropriate Prescribing in Patients with Kidney Disease: A Rapid Review of Prevalence, Associated Clinical Outcomes and Impact of Interventions","volume":"134","author":"Hamzaei","year":"2024","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Onita, T., Ishihara, N., and Yano, T. (2025). PK\/PD-Guided Strategies for Appropriate Antibiotic Use in the Era of Antimicrobial Resistance. Antibiotics, 14.","DOI":"10.3390\/antibiotics14010092"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.ackd.2010.05.007","article-title":"Antibiotic Pharmacokinetic and Pharmacodynamic Considerations in Patients with Kidney Disease","volume":"17","author":"Eyler","year":"2010","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmi.2020.11.032","article-title":"Does Dose Reduction of Renally Cleared Antibiotics in Patients with Impaired Renal Function Lead to Adequate Drug Exposure? A Systematic Review","volume":"27","author":"Zieck","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","article-title":"Overview of Antibiotic-Induced Nephrotoxicity","volume":"8","author":"Campbell","year":"2023","journal-title":"Kidney Int. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Malangu, N. (2017). Toxicity of \u03b2-Lactam Antibiotics: Pathophysiology, Molecular Biology and Possible Recovery Strategies. Poisoning\u2014From Specific Toxic Agents to Novel Rapid and Simplified Techniques for Analysis, InTech.","DOI":"10.5772\/65817"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"De Broe, M.E., Porter, G.A., Bennett, W.M., and Verpooten, G.A. (1998). Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals, Springer.","DOI":"10.1007\/978-94-015-9088-4"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Roger, C., and Louart, B. (2021). Beta-Lactams Toxicity in the Intensive Care Unit: An Underestimated Collateral Damage?. Microorganisms, 9.","DOI":"10.3390\/microorganisms9071505"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1592\/phco.30.12.1279","article-title":"Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing","volume":"30","author":"Lim","year":"2010","journal-title":"Pharmacotherapy"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/jcpt.13464","article-title":"Neurotoxicity Associated with Acyclovir and Valacyclovir: A Systematic Review of Cases","volume":"46","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_16","first-page":"e52367","article-title":"Acyclovir-Induced Nephrotoxicity and Neurotoxicity: A Report of Two Cases","volume":"16","author":"Lim","year":"2024","journal-title":"Cureus"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/0885066614555490","article-title":"Antibiotic Dosing in Patients with Acute Kidney Injury: \u201cEnough But Not Too Much\u201d","volume":"31","author":"Lewis","year":"2016","journal-title":"J. Intensive Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"102667","DOI":"10.5527\/wjn.v14.i3.102667","article-title":"Antimicrobial Dosing Considerations in Critically Ill Patients with Acute Kidney Injury: A Review","volume":"14","author":"Tee","year":"2025","journal-title":"World J. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/gmic.28027","article-title":"Off-Label Abuse of Antibiotics by Bacteria","volume":"5","author":"Viswanathan","year":"2014","journal-title":"Gut Microbes"},{"key":"ref_20","first-page":"277","article-title":"The Antibiotic Resistance Crisis: Part 1: Causes and Threats","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jiac.2023.05.008","article-title":"Clinical Efficacy and Safety of Prolonged versus Intermittent Administration of Antipseudomonal Beta-Lactam Antibiotics in Adults with Severe Acute Infections: A Meta-Analysis of Randomized Controlled Trials","volume":"29","author":"Nadir","year":"2023","journal-title":"J. Infect. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mahmudul Islam, A.F.M., Raihan, M.A., Ahmed, K.T., Islam, M.S., Nusrat, N.A., Hasan, M.A., Emran, M.G.I., Das, A.K., Lamisa, A.B., and Ahmed, T. (2024). Prevalence of Inappropriate Antibiotic Doses among Pediatric Patients of Inpatient, Outpatient, and Emergency Care Units in Bangladesh: A Cross-Sectional Study. PLoS Glob. Public Health, 4.","DOI":"10.1371\/journal.pgph.0003657"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Aguado Paredes, A., Valera Rubio, M., and Mo\u00f1ino-Dominguez, L. (2022). 4CPS-245 Inappropriate Antibiotic Dosage Adjustments in Patients with Renal Impairment: A Cross-Sectional Analysis. Proceedings of the Section 7: Post Congress Additions, British Medical Journal Publishing Group.","DOI":"10.1136\/ejhpharm-2022-eahp.410"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Spernovasilis, N., Kritsotakis, E.I., Mathioudaki, A., Vouidaski, A., Markaki, I., Psaroudaki, D., Ioannou, P., and Kofteridis, D.P. (2022). Antimicrobial Prescribing before and after the Implementation of a Carbapenem-Focused Antimicrobial Stewardship Program in a Greek Tertiary Hospital during the COVID-19 Pandemic. Antibiotics, 12.","DOI":"10.3390\/antibiotics12010039"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1093\/jac\/dkx236","article-title":"Is There Any Difference in Quality of Prescribing between Antibacterials and Antifungals? Results from the First Global Point Prevalence Study (Global PPS) of Antimicrobial Consumption and Resistance from 53 Countries","volume":"72","author":"Yusuf","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A More Accurate Method to Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Chronic Kidney Disease Epidemiology Collaboration Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ki.2011.322","article-title":"Drug Dosing Consideration in Patients with Acute and Chronic Kidney Disease\u2014A Clinical Update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Matzke","year":"2011","journal-title":"Kidney Int."},{"key":"ref_29","unstructured":"Aronoff, G.R. (2009). Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children, American College of Physicians. [5th ed.]. [3. repr.]."},{"key":"ref_30","unstructured":"Sperryville, V.A. (2024). The Sanford Guide to Antimicrobial Therapy 2024, Antimicrobial Therapy, Inc.. [54th ed.]."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11255-021-02834-6","article-title":"Antibiotic Dosing Adjustments in Hospitalized Patients with Chronic Kidney Disease: A Retrospective Chart Review","volume":"54","author":"Chahine","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"ref_32","first-page":"e13449","article-title":"Assessment of Medication Dosage Adjustment in Hospitalized Patients with Chronic Kidney Disease","volume":"13","author":"Hassan","year":"2021","journal-title":"Cureus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2013.09.009","article-title":"Dosing Errors in Prescribed Antibiotics for Older Persons with CKD: A Retrospective Time Series Analysis","volume":"63","author":"Farag","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e13579","DOI":"10.1111\/ijcp.13579","article-title":"Antibiotic Dosing Adjustments in Patients with Declined Kidney Function at a Tertiary Hospital in Jordan","volume":"74","author":"Jarab","year":"2020","journal-title":"Int. J. Clin. Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e4493","DOI":"10.1093\/cid\/ciaa1801","article-title":"Outpatient Antibiotic Prescribing Patterns for Adult End-Stage Renal Disease Patients in New York State","volume":"73","author":"Coritsidis","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.30574\/wjarr.2023.19.3.1841","article-title":"Neharika Lamsal Analysis of Prescription Pattern and Evaluation of Possible Drug Related Problems in Acute Kidney Injury Patients","volume":"19","author":"Mohan","year":"2023","journal-title":"World J. Adv. Res. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/clinids\/12.2.236","article-title":"Adverse Antibiotic Effects Associated with Renal Insufficiency","volume":"12","author":"Manian","year":"1990","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/jac\/dkx209","article-title":"Too Much of a Good Thing: A Retrospective Study of \u03b2-Lactam Concentration\u2013Toxicity Relationships","volume":"72","author":"Imani","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_39","first-page":"e89597","article-title":"Acyclovir-Induced Nephrotoxicity: A Case Report","volume":"17","author":"Chami","year":"2025","journal-title":"Cureus"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s13730-012-0035-0","article-title":"Acute Kidney Injury Due to Acyclovir","volume":"2","author":"Yildiz","year":"2013","journal-title":"CEN Case Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e9310","DOI":"10.1002\/ccr3.9310","article-title":"Acyclovir-induced Psychiatric and Renal Adverse Effects in a Diabetic Patient: A Case Report","volume":"12","author":"Roshanzamiri","year":"2024","journal-title":"Clin. Case Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/cc10257","article-title":"Recommended \u03b2-Lactam Regimens Are Inadequate in Septic Patients Treated with Continuous Renal Replacement Therapy","volume":"15","author":"Seyler","year":"2011","journal-title":"Crit. Care"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/14740338.2024.2443780","article-title":"Use of Antibiotics in Patients with Chronic Kidney Disease: Evidence from the Real World","volume":"25","year":"2026","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mondal, A.H., Khare, K., Saxena, P., Debnath, P., Mukhopadhyay, K., and Yadav, D. (2024). A Review on Colistin Resistance: An Antibiotic of Last Resort. Microorganisms, 12.","DOI":"10.3390\/microorganisms12040772"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Karakonstantis, S., Ioannou, P., Samonis, G., and Kofteridis, D.P. (2021). Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter Baumannii. Antibiotics, 10.","DOI":"10.3390\/antibiotics10111344"},{"key":"ref_46","first-page":"271","article-title":"Pandrug-Resistant Gram-Negative Bacteria: A Systematic Review of Current Epidemiology, Prognosis and Treatment Options","volume":"75","author":"Karakonstantis","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Aitullina, A., Kr\u016bmi\u0146a, A., Svirskis, \u0160., and Purvi\u0146a, S. (2019). Colistin Use in Patients with Extreme Renal Function: From Dialysis to Augmented Clearance. Medicina, 55.","DOI":"10.3390\/medicina55020033"},{"key":"ref_48","unstructured":"(2026, April 06). Drugs.Com. Acyclovir Indications and Dose. Available online: https:\/\/www.drugs.com\/dosage\/acyclovir.html."},{"key":"ref_49","unstructured":"(2026, April 06). Drugs.Com. Cefuroxime Indications and Dose. Available online: https:\/\/www.drugs.com\/dosage\/cefuroxime.html."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41598-025-30634-w","article-title":"Antimicrobial Use, Prescribing Quality, and Therapy-Related Problems among Hospitalized Patients in Northeast Ethiopia","volume":"16","author":"Gobezie","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cmi.2014.09.011","article-title":"The Impact of Drug Interactions and Polypharmacy on Antimicrobial Therapy in the Elderly","volume":"21","author":"Corsonello","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0018578720918363","article-title":"Evaluation of Pharmacist Renal Dose Adjustments and Planning for Future Evaluations of Pharmacist Services","volume":"56","author":"Bassett","year":"2021","journal-title":"Hosp. Pharm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"ooab039","DOI":"10.1093\/jamiaopen\/ooab039","article-title":"Design, Development, and Deployment of an Indication- and Kidney Function-Based Decision Support Tool to Optimize Treatment and Reduce Medication Dosing Errors","volume":"4","author":"Hirsch","year":"2021","journal-title":"JAMIA Open"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Vlak, I., Samard\u017ei\u0107, I., Marinovi\u0107, I., Bu\u0161i\u0107, N., and Vrca, V.B. (2023). Antimicrobial Stewardship and Dose Adjustment of Restricted Antimicrobial Drugs in Hospital Setting. Pharmacy, 11.","DOI":"10.3390\/pharmacy11020068"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"dlac063","DOI":"10.1093\/jacamr\/dlac063","article-title":"Antimicrobial Stewardship Using Electronic Prescribing Systems in Hospital Settings: A Scoping Review of Interventions and Outcome Measures","volume":"4","author":"Jenkins","year":"2022","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref_56","first-page":"27","article-title":"Clinical Decision Support Systems-Based Interventions to Improve Medication Outcomes: A Systematic Literature Review on Features and Effects","volume":"35","author":"Shahmoradi","year":"2021","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41746-025-02127-7","article-title":"Meta-Analysis of Randomized Controlled Trials of Electronic Health Interventions to Reduce Medication Errors","volume":"8","author":"Colin","year":"2025","journal-title":"npj Digit. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1017\/ash.2025.10155","article-title":"Clinical Pharmacist-Led Antimicrobial Stewardship under Volume-Based Procurement: A Retrospective Quasi-Experimental Study on Rational Use and Resistance Control","volume":"5","author":"He","year":"2025","journal-title":"Antimicrob. Steward. Healthc. Epidemiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ajic.2023.11.010","article-title":"Randomized Control Trial on Impact of Clinical Pharmacist Led Interventions on Antibiotic Stewardship Program in Children 0 to 18 Years Age in a Tertiary Care Hospital in Southern India","volume":"52","author":"Unni","year":"2024","journal-title":"Am. J. Infect. Control"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Matusik, E. (2020). Commentary: Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.580163"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/4\/743\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:33:28Z","timestamp":1776083608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/4\/743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["medicina62040743"],"URL":"https:\/\/doi.org\/10.3390\/medicina62040743","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]}}}